Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival

Treating idiosyncratic metastatic tumors with highly focused radiation oregon country did not amended progression-free oregon wide endurance for patients with oligometastatic bosom crab receiving first-line systemic therapy, according to results from the randomized NRG-BR002 objective proceedings led by researchers astatine The University of Texas MD Anderson Cancer Center.